Candriam SCA’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.1M | Sell |
121,418
-6,661
| -5% | -$583K | 0.05% | 275 |
|
|
2026
Q1 | $10.9M | Buy |
128,079
+25,563
| +25% | +$2.28M | 0.06% | 268 |
|
|
2025
Q4 | $8.1M | Sell |
102,516
-233,401
| -69% | -$18.3M | 0.04% | 298 |
|
|
2025
Q3 | $26.9M | Buy |
335,917
+3,908
| +1% | +$333K | 0.14% | 144 |
|
|
2025
Q2 | $30.2M | Sell |
332,009
-8,543
| -3% | -$780K | 0.17% | 114 |
|
|
2025
Q1 | $31.9M | Sell |
340,552
-9,121
| -3% | -$817K | 0.2% | 109 |
|
|
2024
Q4 | $31.8M | Buy |
349,673
+72,175
| +26% | +$6.89M | 0.18% | 109 |
|
|
2024
Q3 | $28.8M | Buy |
277,498
+31,945
| +13% | +$3.26M | 0.17% | 129 |
|
|
2024
Q2 | $23.8M | Buy |
245,553
+8,693
| +4% | +$802K | 0.14% | 144 |
|
|
2024
Q1 | $21.3M | Buy |
236,860
+2,883
| +1% | +$244K | 0.14% | 157 |
|
|
2023
Q4 | $18.7M | Sell |
233,977
-216,005
| -48% | -$16.2M | 0.13% | 164 |
|
|
2023
Q3 | $32M | Sell |
449,982
-31,473
| -7% | -$2.35M | 0.23% | 90 |
|
|
2023
Q2 | $37.1M | Sell |
481,455
-50,490
| -9% | -$3.91M | 0.27% | 90 |
|
|
2023
Q1 | $36.8M | Sell |
531,945
-22,435
| -4% | -$1.67M | 0.26% | 93 |
|
|
2022
Q4 | $43.7M | Buy |
554,380
+88,832
| +19% | +$6.66M | 0.29% | 83 |
|
|
2022
Q3 | $32.7M | Buy |
465,548
+267,241
| +135% | +$21M | 0.23% | 100 |
|
|
2022
Q2 | $15.9M | Sell |
198,307
-110,221
| -36% | -$8.62M | 0.13% | 169 |
|
|
2022
Q1 | $23.4M | Buy |
308,528
+27,680
| +10% | +$2.19M | 0.16% | 146 |
|
|
2021
Q4 | $24M | Sell |
280,848
-26,568
| -9% | -$2.07M | 0.15% | 156 |
|
|
2021
Q3 | $23.2M | Buy |
307,416
+48,273
| +19% | +$3.83M | 0.16% | 150 |
|
|
2021
Q2 | $21.1M | Buy |
259,143
+126,326
| +95% | +$10.3M | 0.14% | 169 |
|
|
2021
Q1 | $10.9M | Buy |
132,817
+20
| +0% | +$1.57K | 0.09% | 239 |
|
|
2020
Q4 | $11.4M | Buy |
132,797
+5,682
| +4% | +$470K | 0.09% | 243 |
|
|
2020
Q3 | $9.81M | Buy |
127,115
+5,819
| +5% | +$444K | 0.09% | 240 |
|
|
2020
Q2 | $8.89M | Sell |
121,296
-35,946
| -23% | -$2.55M | 0.09% | 233 |
|
|
2020
Q1 | $10.6M | Buy |
157,242
+16
| +0% | +$1.13K | 0.12% | 202 |
|
|
2019
Q4 | $10.8M | Buy |
157,226
+5,059
| +3% | +$345K | 0.12% | 204 |
|
|
2019
Q3 | $11.2M | Sell |
152,167
-15,214
| -9% | -$1.1M | 0.15% | 161 |
|
|
2019
Q2 | $12.9M | Sell |
167,381
-32,945
| -16% | -$2.34M | 0.16% | 147 |
|
|
2019
Q1 | $14.6M | Sell |
200,326
-59,168
| -23% | -$3.82M | 0.19% | 120 |
|
|
2018
Q4 | $15.4M | Buy |
259,494
+14,727
| +6% | +$921K | 0.24% | 97 |
|
|
2018
Q3 | $16.4M | Sell |
244,767
-222,225
| -48% | -$14.8M | 0.22% | 111 |
|
|
2018
Q2 | $30.3M | Sell |
466,992
-26,825
| -5% | -$1.75M | 0.48% | 41 |
|
|
2018
Q1 | $35.4M | Sell |
493,817
-154,709
| -24% | -$11.1M | 0.6% | 26 |
|
|
2017
Q4 | $48.9M | Buy |
648,526
+136,541
| +27% | +$9.97M | 0.85% | 14 |
|
|
2017
Q3 | $37.3M | Sell |
511,985
-104,901
| -17% | -$7.56M | 0.65% | 26 |
|
|
2017
Q2 | $45.7M | Buy |
616,886
+269,381
| +78% | +$20M | 0.86% | 16 |
|
|
2017
Q1 | $25.4M | Buy |
347,505
+154,785
| +80% | +$10.8M | 0.49% | 37 |
|
|
2016
Q4 | $12.6M | Sell |
192,720
-53,177
| -22% | -$3.65M | 0.29% | 93 |
|
|
2016
Q3 | $18.2M | Sell |
245,897
-18,964
| -7% | -$1.4M | 0.44% | 56 |
|
|
2016
Q2 | $19.4M | Buy |
264,861
+219,459
| +483% | +$15.6M | 0.5% | 47 |
|
|
2016
Q1 | $3.19M | Sell |
45,402
-10,301
| -18% | -$685K | 0.08% | 257 |
|
|
2015
Q4 | $3.71M | Sell |
55,703
-320,457
| -85% | -$21.3M | 0.1% | 219 |
|
|
2015
Q3 | $23.9M | Sell |
376,160
-228,073
| -38% | -$14.9M | 0.59% | 35 |
|
|
2015
Q2 | $39.5M | Buy |
604,233
+81,492
| +16% | +$5.53M | 0.82% | 18 |
|
|
2015
Q1 | $36.3M | Buy |
522,741
+981
| +0.2% | +$67.8K | 0.73% | 24 |
|
|
2014
Q4 | $36.1M | Buy |
+521,760
| New | +$35.2M | 0.75% | 25 |
|
Other funds holding CL
Candriam SCA's CL Position: Q2 2026 in Review
Candriam SCA reduced its Colgate-Palmolive (CL) stake by 5.2% in Q2 2026, selling an estimated $583K and leaving 121,418 shares worth $11.1M. The position accounts for 0.05% of the portfolio, ranked #275.
Candriam SCA first reported a position in CL in Q4 2014 and has held it in 47 quarters since. The position peaked at $48.9M in Q4 2017. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Candriam SCA held 121,418 shares of Colgate-Palmolive worth $11.1M as of Q2 2026.
- Candriam SCA sold 6,661 Colgate-Palmolive shares in Q2 2026, an estimated $583K.
- Colgate-Palmolive made up 0.05% of Candriam SCA's portfolio in Q2 2026, its #275 holding.
- Candriam SCA first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Colgate-Palmolive position peaked at $48.9M in Q4 2017.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.